Résultats: 87

    Policy summary 5: health policy responses to the financial crisis in Europe

    Economic shocks present policy-makers with three main challenges:o Health systems require predictable sources of revenue. Sudden interruptions to public revenue streams can make it difficult to maintain necessary levels of health care.o Cuts to public spending on health made in response to an economic sh...

    Policy dialogue Increasing Access to Skilled Birth Attendance: report

    The REACH policy initiative SURE project under UNHRO in collaboration with the College of Health Sciences, Makerere University had produced a policy brief on increasing access to skilled birth attendance which was the focus for discussion in this meeting. The brief describes the problem, highlights three...

    Improving governance for health district development in Cameroon: executive summary

    The poor governance in Cameroonian health districts stems from a lack of clear and consistent operating procedures for district governing bodies and health services, power imbalance between district managers and community representatives, and insufficient knowledge of the existing legal and regulatory fr...

    Reducing maternal mortality in Morocco: sharing experience and sustaining progress

    Although not using EVIPNet methodologies yet, this policy brief is helpful in showing how Morocco has implemented efficient strategies of intervention to accelerate the reduction of maternal mortality. The exercise of the evidence informed policy brief writing with multisectoral health players such as UN...

    Conditional cash transfer programmes: a magic bullet to improve people's health and education?

    Conditional Cash Transfer (CCTs) programmes provide cash to poor households who meet certain health and education conditions such as regular school attendance and health check-ups for children at the clinic. This model of intervention is spreading rapidly throughout the developing world. Over 17 countrie...

    Policy brief on improving access to artemisinin-based combination therapies for malaria in Central African Republic

    In the Central African Republic (CAR) malaria is a major public health problem and hampers socioeconomic development. It accounts for 40 percent of complaints and 10 percent of deaths in health facilities (15;17). Pregnant women, who make up 4 percent of the population, and children under 5 years of age,...

    Policy brief on improving access to artemisinin-based combination therapies for malaria in Cameroon

    Malaria is the major cause of illness in Cameroon, responsible for 40 percent of medical consultations. For this reason, the Head of State along with his African Union peers in April 2000 and 2006 undertook to achieve universal access to malaria control interventions, including effective treatment (10;12...

    Policy brief on improving access to artemisinin-based combination therapies for malaria control in Ethiopia

    Malaria in Ethiopia is one of the leading causes of death (21.8 percent), consultation in outpatient departments (17.8 percent) and hospital admissions (14.1 percent) (2;14). To overcome this problem, the Malaria Control Program (Federal Ministry of Health) has designed a communitybased malaria treatment...

    Policy brief on improving access to artemisinin-based combination therapies for malaria in Mozambique

    Malaria is a major cause of morbidity and mortality in Mozambique. Approximately 6 million cases are reported each year. Malaria accounts for approximately 40 percent of all outpatient visits and 60 percent of pediatric hospital admissions. It is the leading cause of death among children admitted to pedi...

    Policy brief on improving access to artemisinin-based combination therapies for malaria in the East African community

    The World Health Organization (WHO) since June 1998 has advocated for the use of artemisinin-based combination therapies (ACTs) in countries where Plasmodium falciparum malaria is resistant to traditional antimalarial therapies such as chloroquine, sulfadoxine-pyrimethamine, and amodiaquine (19;22). In 2...